NIH

The Senate agreement is now before the House, which needs to act by midnight to avert a shutdown. The deal appears to include almost every health priority Democrats have been pushing in recent months.

Federal researchers are collecting blood samples from 1 million Americans as part of an effort called "precision medicine." But some critics worry that the path ahead is expensive and unclear.

If the former drug company executive is confirmed by the Senate, he would replace Dr. Tom Price, who resigned in September after a scandal involving government travel on private aircraft.

One California university is trying a new strategy to help minority students perform better in STEM classes and develop the mental resilience to face future challenges.

The relationship has been fraught with disputes about which research should be funded. Four House members have asked NFL Commissioner Roger Goodell whether the league plans to honor its commitment.

Three genetic changes could be enough to make a bird flu strain that's already killing some people in China highly contagious. Are experiments with a deliberately mutated version too risky?

Some members of Congress say the U.S. government should use the patent rights it owns for any drugs that were developed with federal grants to drive down the prices of those drugs.

Sweeping legislation that would reshape how the Food and Drug Administration reviews new products and bolster National Institutes of Health funding is moving closer to becoming law. What's at stake?

The House could vote Wednesday on a vast bill that stretches nearly a thousand pages and holds changes large and small for the National Institutes of Health and the Food and Drug Administration.